GL
IDXX icon

GLG LLC’s Idexx Laboratories IDXX Stock Holding History

GLG LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$673K Sell
4,301
-9,600
-69% -$1.51M 0.05% 304
2017
Q3 		$2.16M Sell
13,901
-1,293
-9% -$204K 0.14% 188
2017
Q2 		$2.45M Buy
15,194
+9,396
+162% +$1.53M 0.15% 186
2017
Q1 		$896K Buy
+5,798
New +$799K 0.05% 356

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

GLG LLC's IDXX Position: Q4 2017 in Review

GLG LLC reduced its Idexx Laboratories (IDXX) stake by 69% in Q4 2017, selling an estimated $1.51M and leaving 4,301 shares worth $673K. The position accounts for 0.05% of the portfolio, ranked #304.

GLG LLC first reported a position in IDXX in Q1 2017 and has held it in 4 quarters since. The position peaked at $2.45M in Q2 2017. 613 funds tracked by Wall St. Rank hold IDXX as of Q4 2017.

  • GLG LLC held 4,301 shares of Idexx Laboratories worth $673K as of Q4 2017.
  • GLG LLC sold 9,600 Idexx Laboratories shares in Q4 2017, an estimated $1.51M.
  • Idexx Laboratories made up 0.05% of GLG LLC's portfolio in Q4 2017, its #304 holding.
  • GLG LLC first reported a position in Idexx Laboratories in Q1 2017 and has held it in 4 quarters since.
  • GLG LLC's Idexx Laboratories position peaked at $2.45M in Q2 2017.
  • 613 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.